Cellectis S.A. American Depositary Shares (CLLS) is a publicly traded Healthcare sector company. As of October 28, 2026, CLLS trades at $1.14 with a market cap of $97.36M and a P/E ratio of 0.00. CLLS moved +8.57% today. Year to date, CLLS is -78.13%; over the trailing twelve months it is -71.07%. Its 52-week range spans $0.88 to $5.48. Analyst consensus is neutral with an average price target of $4.10. Rallies surfaces CLLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CLLS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.14 |
| Market Cap | $97.36M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.48 |
| 52-Week Low | $0.88 |
| Volume | 60.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover CLLS: 0 strong buy, 1 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $4.10.